Gainers
- MSP Recovery LIFW shares increased by 38.0% to $2.94 during Wednesday's regular session. The market value of their outstanding shares is at $42.3 million.
- Liquidia LQDA shares rose 37.98% to $10.88. The company's market cap stands at $745.6 million.
- ENDRA Life Sciences NDRA shares rose 27.48% to $2.18. The company's market cap stands at $18.4 million.
- Beyond Air XAIR stock increased by 20.58% to $2.05. The company's market cap stands at $65.5 million.
- Vicarious Surgical RBOT stock rose 19.14% to $0.36. The company's market cap stands at $62.6 million.
- Conduit Pharmaceuticals CDT stock rose 18.89% to $4.97. The company's market cap stands at $366.9 million.
Losers
- bluebird bio BLUE stock decreased by 44.7% to $1.34 during Wednesday's regular session. The market value of their outstanding shares is at $147.1 million.
- Tonix Pharmaceuticals TNXP shares fell 35.07% to $0.39. The company's market cap stands at $9.2 million.
- Jin Medical International ZJYL stock declined by 28.9% to $80.98. The market value of their outstanding shares is at $627.5 million.
- Know Labs KNW stock decreased by 28.38% to $0.54. The company's market cap stands at $43.3 million. The company's, Q4 earnings came out yesterday.
- argenx ARGX shares decreased by 25.79% to $335.88. The market value of their outstanding shares is at $19.8 billion.
- Panbela Therapeutics PBLA shares decreased by 25.45% to $1.17. The market value of their outstanding shares is at $6.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BLUEbluebird bio Inc
$7.720.78%
CDTConduit Pharmaceuticals Inc
$0.05724.95%
KNWKnow Labs Inc
$0.163010.1%
LQDALiquidia Corp
$11.530.79%
NDRAENDRA Life Sciences Inc
$5.20-7.14%
PBLAPanbela Therapeutics Inc
$0.35202.20%
RBOTVicarious Surgical Inc
$12.12-6.19%
TNXPTonix Pharmaceuticals Holding Corp
$0.3889-3.52%
XAIRBeyond Air Inc
$0.4400-0.29%
ZJYLJin Medical International Ltd
$0.999911.1%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in